4.0 Article

National Trends in the Treatment for Depression From 1998 to 2007

Journal

ARCHIVES OF GENERAL PSYCHIATRY
Volume 67, Issue 12, Pages 1265-1273

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archgenpsychiatry.2010.151

Keywords

-

Categories

Funding

  1. Bristol-Myers Squibb
  2. Eli Lilly Company
  3. Agency for Healthcare Research and Quality [U18-HS016097]

Ask authors/readers for more resources

Context: The rate of outpatient treatment of depression increased markedly in the United States between 1987 and 1997; it is not known whether this trend has continued. Objective: To assess national trends in the outpatient treatment of depression between 1998 and 2007. Design and Setting: Analysis of service utilization data from 2 nationally representative surveys of the US household population, the 1998 (n=22 953) and 2007 (n=29 370) Medical Expenditure Panel Surveys. Participants: Nationally representative sample of the US household population. Main Outcome Measures: The rate of depression treatment and, among patients who received treatment, the rate of antidepressant medication use, psychotherapy, number of outpatient treatment visits, and expenditures. Results: The rate of outpatient treatment for depression increased from 2.37 per 100 persons in 1998 to 2.88 per 100 persons in 2007 (adjusted odds ratio [AOR], 1.18; 95% confidence interval [CI], 1.03-1.35). The percentage of treated patients who used antidepressants was little changed from 73.8% (1998) to 75.3% (2007) (AOR, 1.14; 95% CI, 0.85-1.51), but the percentage of those receiving psychotherapy declined from 53.6% (1998) to 43.1% (2007) (AOR, 0.71; 95% CI, 0.53-0.95). National expenditures for the outpatient treatment of depression increased from $10.05 billion to $12.45 billion (z=1.73, P=.08). This was primarily driven by an increase in medication expenditures from $4.59 billion (1998) to $6.60 billion (2007) (z=2.88, P=.004), which in turn was related to an increase in Medicare expenditures for depression treatment from $0.52 billion (1998) to $2.25 billion (2007) (z=5.62, P<.001). Conclusions: Rapid increases in depression treatment from 1987 to 1997 were followed by more modest increases during the following decade. Although there was little change in the proportion of patients receiving antidepressants, treatment with psychotherapy has declined.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available